Search
Displaying 531–540 of 894 results for “vision connection”
-
The Foundation Fighting Blindness, the world’s leading private funding source for retinal degenerative disease research, will host online continuing medical education (CME and COPE) courses throughout the year. The continuing education courses will review a number of topics related to care and management of patients with inherited retinal diseases.
-
jCyte Reports Promising Results for Phase 2b Clinical Trial of its Cellular Therapy for RP
Research NewsThe emerging therapy is designed to work independent of the mutated gene causing vision loss
-
Beacon Stories My Retina Tracker Patient Stories
Allen has always wanted to be known as an artist, first and foremost. His photography hints at the ever-changing nature of people’s lives and their environment, much like his own progression with retinitis pigmentosa (RP).
-
jCyte Enters into Licensing Agreement with Santen Pharmaceutical for Cell Therapy
Research NewsEmerging treatment designed to preserve vision for people with RP and related conditions
-
Interim Results Released for USH2A RNA Therapy Clinical Trial
Research NewsSuggestions of efficacy observed in 25 percent of participants receiving the treatment
-
Foundation News
The Foundation Fighting Blindness is closely monitoring the COVID-19 situation and its impact on the IRD community.
-
Beacon Stories
“I decided to include the Foundation in my estate plans,” Anne explained, “so that if the time ever comes when my grandchildren, or anyone else’s, experience vision loss, the scientists will have figured out how to help them.”
-
Foundation Joins the Institute for Gene Therapies, a Newly Formed Advocacy Organization
Research NewsIGT to accelerate gene therapy development and patient access
-
AGTC Reports Positive Six-Month Results for XLRP Phase 1/2 Gene Therapy Trial
Research NewsThe company is planning a Phase 3, pivotal trial for end of 2020
